Researchers identified a strong association between GLP-1 medications and reduced rates of multiple substance use disorders, raising new questions about how these drugs may affect the brain’s reward system. What if some of the world’s most popular weight loss drugs are affecting more than appetite? A new study suggests that GLP-1 medications, a class of [...]

The most

A widely prescribed class of weight-loss and diabetes medications may be doing more than improving metabolic health. Drugs such as Ozempic and Wegovy have transformed the treatment of obesity and type 2 diabetes, helping millions lose weight and improve metabolic health. But scientists are increasingly uncovering effects that extend far beyond the scale. Research has [...]

Scientists may have found the brain-cell switch that determines how long Ozempic’s weight-loss effects last. Researchers at the National Institutes of Health (NIH) have gained new insight into how GLP-1 receptor agonists such as semaglutide produce their weight-loss effects. While scientists have long known which areas of the brain are involved, much less has been [...]